Host adaptation of a bacterial toxin from the human pathogen Salmonella Typhi.

Cell

Glycobiology Research and Training Center, University of California, San Diego, La Jolla, CA 92093, USA; Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA; Department of Pathology, University of California, San Diego, La Jolla, CA 92093, USA; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address:

Published: December 2014

Salmonella Typhi is an exclusive human pathogen that causes typhoid fever. Typhoid toxin is a S. Typhi virulence factor that can reproduce most of the typhoid fever symptoms in experimental animals. Toxicity depends on toxin binding to terminally sialylated glycans on surface glycoproteins. Human glycans are unusual because of the lack of CMAH, which in other mammals converts N-acetylneuraminic acid (Neu5Ac) to N-glycolylneuraminic acid (Neu5Gc). Here, we report that typhoid toxin binds to and is toxic toward cells expressing glycans terminated in Neu5Ac (expressed by humans) over glycans terminated in Neu5Gc (expressed by other mammals). Mice constitutively expressing CMAH thus displaying Neu5Gc in all tissues are resistant to typhoid toxin. The atomic structure of typhoid toxin bound to Neu5Ac reveals the structural bases for its binding specificity. These findings provide insight into the molecular bases for Salmonella Typhi's host specificity and may help the development of therapies for typhoid fever.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258231PMC
http://dx.doi.org/10.1016/j.cell.2014.10.057DOI Listing

Publication Analysis

Top Keywords

typhoid toxin
16
typhoid fever
12
human pathogen
8
salmonella typhi
8
glycans terminated
8
typhoid
7
toxin
6
host adaptation
4
adaptation bacterial
4
bacterial toxin
4

Similar Publications

Fowl typhoid (FT) poses a significant threat to the poultry industry and can cause substantial economic losses, especially in developing regions. Caused by Salmonella Gallinarum (SG), vaccination can prevent FT. However, existing vaccines, like the SG9R strain, have limitations, including residual virulence and potential reversion of pathogenicity.

View Article and Find Full Text PDF
Article Synopsis
  • * In a study conducted in Northwest Ethiopia from June 2022 to August 2023 across 58 dairy farms, 362 samples were tested for NTS, resulting in detection of 28 isolates (7.7%), with S. Uganda being the most prevalent serovar.
  • * The study found that 100% of NTS isolates had the invA virulence gene, 21.4% had spvC, and a high proportion (89.3%) were resistant to at least
View Article and Find Full Text PDF

Non-typhoidal (NTS) is a major global foodborne pathogen that poses a major public health concern worldwide, and no vaccines are available for protecting against infection of multiple serotypes, therefore, the development of vaccines to provide broad protection is valuable. In this work, we aimed to regulate lipopolysaccharide (LPS) synthesis of live for exposing conserved protein antigens on the outer membrane while maintaining smooth LPS patterns to keep their original ability to invade host cells for inducing cross-protection against infection of multiple serotypes. We generated a series of mutants defective in genes to affect the length of LPS.

View Article and Find Full Text PDF

Comparative genomic analysis provides new insights into non-typhoidal Salmonella population structure in Peru.

Sci Rep

November 2024

Laboratorio de Referencia Nacional de Bacteriología Clínica, Instituto Nacional de Salud, Lima, Peru.

Article Synopsis
  • Non-typhoidal Salmonella (NTS) is a major cause of foodborne outbreaks globally, especially in countries like Peru, necessitating an analysis of its circulating serotypes.
  • Researchers studied the genomes of 1122 NTS strains from 1998 to 2018, identifying 40 different Sequence Types (STs), with ST-32 and ST-11 being the most prevalent.
  • The study revealed that strains within the same ST are genetically similar and that certain virulence factors and drug resistance are strongly associated with these common STs, indicating their adaptation in the region.
View Article and Find Full Text PDF

Systemic vaccination of macaques with V1-deleted (ΔV1) envelope immunogens reduce the risk of SIV acquisition by approximately 60%, with protective roles played by V2-specific ADCC and envelope-specific mucosal IL-17NKp44 innate lymphoid cells (ILCs). We investigated whether increased mucosal responses to V2 benefit vaccine efficacy by delivering oral nanoparticles (NPs) that release V2-scaffolded on Typhoid Toxin B (TTB) to the large intestine. Strikingly, mucosal immunization of male macaques abrogated vaccine efficacy with control TTB or empty NPs, but vaccine efficacy of up to 47.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!